Photys
Bryan Song is the current Director at Photys. Bryan was previously the Associate Director of Market Planning and Insights at FORMA Therapeutics, Inc. from January 2020 to March 2022. Bryan was responsible for a $1M budget and managed external vendors. Bryan also led primary and secondary insights generation across the company's portfolio, including indication prioritization, claims analysis, Monte Carlo simulation, competitive intelligence, product positioning, business development, and 5-year Corporate Strategy. Prior to that, they were an Engagement Manager at L.E.K. Consulting from June 2017 to January 2020.
Bryan Song graduated from Dartmouth College with a BA in English. Bryan then attended Tulane University School of Medicine, where they earned their Doctor of Medicine (MD). After completing their medical training, Bryan Song enrolled in a Master of Business Administration (MBA) program at Columbia Business School.
Bryan Song reports to (To Be Hired), CEO. They are on a team with (To Be Hired) - CBO, Emma Seabrook - Director of Talent, and Ed Holson - CSO.
This person is not in any teams
This person is not in any offices
Photys
3 followers
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms. Photys was co-founded by the Broad Institute’s leading bifunctional chemist, Amit Choudhary, and the Longwood Fund, alongside a scientific advisory board comprised of distinguished scientists and drug developers – MIT’s Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, MPM’s Wendy Young, and Dana Farber’s Eric Fischer.
Employees
11-50